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Toxocara  canis is  regarded  as  the  main  cause  of  human  toxocarosis  but  the  relative  con-
tribution of  T.  cati is  probably  underestimated;  serological  and  other  diagnostic  methods
used in  most  studies  of this  zoonotic  disease  do  not  distinguish  between  the two  parasites.
The  deﬁnitive  hosts  for  T.  canis  are  caniidae.  Pups  generally  have higher  infection  rates
than adult  animals  and  are  a major  source  of  eggs  in the environment.  Humans  usually
acquire  T.  canis  infection  by  accidental  ingestion  of  embryonated  eggs  or encapsulated  lar-
vae from  the  environment  or contaminated  food,  such  infections  may  lead  to  visceral  larva
migrans (VLM),  ocular  larva  migrans  (OLM)  or  covert  toxocarosis  (CT).  Although  a mixed
Th1- and  Th2-mediated  immunological  response,  particularly  with  high  levels  of  IgE  and
eosinophilia  is  observed,  the underlying  mechanisms  of  molecular  and  immunopathogen-
esis  for  the  development  of  the  symptomatic  syndromes  of VLM,  OLM,  or of asymptomatic
CT are  largely  unclear.  Studies  have  indicated  that  immunological  defences  against  various
infectious diseases  may  be  highly  inﬂuenced  by complex  interactions  of  environmental  and
host genetic  factors  e.g.  MHC  class  I  and  II, also  known  as human  leucocyte  antigen  (HLA).
Toxocara  spp.  infections  are  associated  with  a polarized  CD4+ Th2  response  with  high  IgE
levels and  eosinophilia,  mediated  mainly  by  HLA  class  II molecules.  Associations  have  been
made between  HLA  class  II and  pathological  severity  and  host  genetic  effects  on  exposure  to
infection. Recent  research  suggests  Foxp3+ CD4+CD25+-expressing  T  regulatory  (Treg)  cells
play a role  in regulation  of  the  immunopathology  of granulomas  in experimental  toxocaral
granulomatous  hepatitis  and  in  enhanced  expression  of  TGF-1,  which  is an  important
factor  for  the  local  survival  and  function  of  Treg  observed  during  T. canis  invasion  in  the
mouse  small  intestine,  liver,  muscle,  and  brain.  Since  the  potential  susceptibility  loci HLA
class II molecules,  are  considered  involved  in  the  regulation  of  a Th2-dominant  immunity
which is  highly  controlled  by  Foxp3+ CD4+CD25+ Treg  cells  by stimulation  through  TGF-1,
which  thus  provides  a beneﬁcial  environment  to T.  canis  larvae  but  severe  injuries  to  local
organs. However,  TGF-1  variant  Leu10Pro  known  to be  involved  in  disease  severity  warr-
ants further  elucidation  as  this  too  may  have  a role  in  the  severity  of  human  toxocarosis.
Exploration  of  TGF-1  polymorphism,  Foxp3+ CD4+CD25+ Treg  cells,  and  MHC  polymor-
phisms  may  allow  insight  into  the  contribution  made  by  environmental  and genetic  factors
in inﬂuencing  disease  syn
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1. Life cycle of Toxocara spp.
Open access under CC BY license.The genus Toxocara belongs to class Nematoda, order
Ascaroidea, and Superfamily Ascaridoidea and comprises
21  species. Toxocara canis and T. cati are the most commonly
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involved species in human toxocarosis (Despommier,
2003). Nevertheless, the ascarids responsible for causing
toxocarosis in the human host are mainly T. canis and prob-
ably  to a lesser extent, T. cati. The deﬁnitive hosts of T.
canis  and T. cati are the dog and cat respectively, inhab-
iting the lumen of the small intestine. Worldwide surveys
of  T. canis occurrence showed that the prevalence ranged
from  86 to 100% in pups and 1 to 45% in adult dogs (Barriga,
1988; Habluetzel et al., 2003; Sowemimo, 2007; Batchelor
et  al., 2008; Dai et al., 2009; Rohen, 2009; Soriano et al.,
2010).  The proportion of cats infected with T. cati appears
relatively high for example 79% of stray cats in a survey
conducted in Denmark, and 91% of feral farm cats in the UK
were  found to be infected (Fisher, 2003). Following infec-
tion  of deﬁnitive hosts, larvae may  penetrate through the
small  intestine then enter the circulation and the juvenile
parasites may  go on to complete the life cycle. Transplacen-
tal infection is common in dogs but in contrast, lactogenic
transmission of T. cati is the most signiﬁcant route of infec-
tion  to kittens (Overgaauw, 1997). Worms  develop to the
adult  stage in the small intestine about 4–5 weeks after the
larvae  hatch. Fertilized female worms may  release several
hundred thousand non-embryonated eggs per day, con-
tributing to high levels of environmental contamination
via the faeces. Embryonation occurs in the soil within two
to  ﬁve weeks, depending on the temperature and humid-
ity  (Despommier, 2003). At 12–18 ◦C this requires 54 days
for  the eggs to become infective whereas at 25–30 ◦C the
time  was shortened to 14 days. However, infective eggs
have  been shown to survive under optimal circumstances
for at least 1 year (Lloyd, 1993). The importance of T. cati
as  a cause of human toxocarosis has yet to be fully evalu-
ated;  as several studies have implicated the parasite as the
causative  agents of ocular larva migrans (OLM) in patients
and  a deﬁnitive investigation on the impact on human
health is required (Fisher, 2003).
2. Human toxocarosis and clinical spectrum
T. canis is the main cause of human toxocarosis
which constitutes a serious epidemiological issue in many
countries. Humans are one of many paratenic hosts, becom-
ing  infected mainly by ingestion of parasite eggs, or to a
lesser  extent by the consumption of chicken or cow liv-
ers  (Despommier, 2003; Morimatsu et al., 2006; Yoshikawa
et  al., 2008; Choi et al., 2012).
Although, many infections caused by Toxocara spp. are
asymptomatic, larval migration into internal organs via the
blood  can lead to a variety of clinical syndromes e.g. vis-
ceral  larva migrans (VLM) and ocular larva migrans (OLM)
(Glickman, 1993; Fan et al., 2003).
The manifestation of symptoms in human toxocaro-
sis depends on many factors, including which organs
are affected and the magnitude of the infection. How-
ever, toxocarosis is usually a non-fatal disease. Varying
degrees of inﬂammatory injuries in cases of paediatric or
adult  toxocarosis associated with granulomatous hepatitis,
asthma, endomyocarditis, generalized lymphadenopathy,
endophthalmitis, cutaneous manifestation and menin-
goencephalitis have been uncommonly reported (Chan
et  al., 2001; Vidal et al., 2003; Gavignet et al., 2008; Lópezlogy 193 (2013) 342– 352 343
Mde  et al., 2010; Salvador et al., 2010; Stoicescu et al., 2011;
Caldera  et al., 2012; Damasceno and Damasceno, 2012).
Additionally, there is now considerable interest in the role
of  T. canis in epilepsy, particularly partial epilepsy (Bächli
et  al., 2004; Nicoletti et al., 2007; Quattrocchi et al., 2012).
Also,  it is reported that cerebral toxocarosis in a woman
from Germany progressed to cognitive defects i.e. dementia
(Richartz and Buchkremer, 2002). Because of the variability
of  the signs and symptoms of the disease, toxocarosis was
divided  into two  main forms in 1988: VLM and ocular toxo-
carosis  (OT) (Taylor et al., 1988). Between 1992 and 1993, a
third  clinical form called covert toxocarosis was  described
in  seropositive patients, with gastrointestinal disturbances,
weakness, and lethargy (Nathwani et al., 1992; Rasmussen
et  al., 1993). Currently, human toxocarosis is clinically clas-
siﬁed  into four major types (Smith et al., 2009).
2.1. Visceral larva migrans (VLM)
In general, high parasitic loads or repeated infec-
tion can lead to VLM (Kayes, 1997). Typical patients are
children aged between 1 and 7 years, but infection is
common in adults. Potential symptoms and other clini-
cal  ﬁndings include fever, hepatomegaly, abdominal pain,
vomiting,  diarrhoea, coughing/wheezing, asthma, inap-
petence, weight loss, fatigue and headache. Occasionally
in toxocaral hepatitis, multiple nodules are detected as
low-density lesions on computed tomography in the liver
(Stoicescu et al., 2011).
2.2.  Ocular larva migrans (OLM)
OLM usually occurs in children aged between 5 and 10
years  and typical syndrome presents as unilateral vision
impairment accompanied by occasional strabismus. Larval
invasion  of the retina usually leads to granuloma forma-
tion,  which occurs typically peripherally or in the posterior
pole.  These granulomas drag the retina and create a distor-
tion,  heterotopia, or detachment of the macula, commonly
resulting in blindness; although visual acuity impairment
depends on the speciﬁc area involved (Gillespie et al.,
1993;  Woodhall et al., 2012). OLM can also cause dif-
fuse  endophthalmitis or papillitis; secondary glaucoma can
follow.  Long-term infection with Toxocara spp. sometimes
leads to a choroidal neovascular membrane formed after
presenting earlier as chorioretinitis (Despommier, 2003).
The  risk factors identiﬁed for patients who  have OT include
geophagia, convulsions, prior dog ownership, and ingestion
of  raw meats and snails (Lee et al., 2010).
2.3. Neurotoxocarosis (NT)
The  site of the CNS invasion includes the brain and
spinal cord and is referred to as neurotoxocarosis (NT)
which depends on multiple factors e.g. the number of
ingested larvae, genetic factors of the host, and previous
exposure may  all contribute to complicated pathogene-
sis of the NT (Xinou et al., 2003). Although the frequency
and localization of Toxocara spp. larvae in the CNS in
humans is unknown, cases of CNS involvement compris-
ing  meningitis, encephalitis, myelitis, cerebral vasculitis,
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eizures or optic neuritis have been uncommonly reported.
T  is likely to be related to the number of larvae entering
he brain or spinal cord, the severity of subsequent CNS
amage and inﬂammation. Following these manifestations,
ffected patients complain about headache, fever, oversen-
itivity to light, weakness, dorsalgia, confusion, tiredness
nd  visual impairment (Xinou et al., 2003; Caldera et al.,
012).
.4.  Covert or common toxocarosis (CT)
Most human infections with Toxocara spp. present far
ess  severe systemic manifestations, if any. In general, the
eropositive subjects detected in population-based sur-
eys  are asymptomatic or only have non-speciﬁc or mild
ymptoms. The results of two case–control studies in
reland and France led to the description of a new clinical
ntity in seropositive children and adults that was named
covert  or common toxocarosis’, respectively (Taylor et al.,
987,  1988; Magnaval et al., 1994). Covert toxocarosis
as characterized clinically in children by fever, anorexia,
eadache, abdominal pain, nausea, vomiting, lethargy,
leep and behavioural disorders, pharyngitis, pneumonia,
ough, wheezing, limb pains, cervical lymphadenitis and
epatomegaly. Common toxocarosis in adults was char-
cterized clinically by weakness, pruritus, rash, difﬁcult
reathing, and abdominal pain (Magnaval et al., 1994).
It  is likely that many people with these clinical forms of
oxocara spp. infection often go undiagnosed because these
linical  manifestations are non-speciﬁc.
. Diagnostics in clinical practice
Given multiple sections and considerable expertise, the
xamination of a biopsy of the affected tissue can provide a
eﬁnitive  diagnosis but such biopsies are rarely available.
t  the moment, in epidemiology, supportive and conﬁr-
ative diagnosis of human toxocarosis has to be assessed
argely by immunodiagnostic or molecular techniques.
n ELISA based on T. canis larval excretory–secretory
TES) antigens, for example, offers a sensitive and spe-
iﬁc  method for the detection of T. canis infections in
umans (Fan et al., 2004a; Jones et al., 2008; Smith et al.,
009)  but the usefulness of such assays is reduced by the
roblem  of antigenic cross-reactivity, especially in unde-
eloped countries where polyparasitism is common (Smith
t  al., 2009). Western blotting based on the fractionated,
ative, excretory–secretory antigens of T. canis larvae (TES-
B)  can give better speciﬁcity, with reactivity to bands
f  low molecular weight (24–32 kDa) proven to be spe-
iﬁc  for T. canis infection (Smith et al., 2009). However,
estern blotting is more expensive and labour-intensive
han ELISA; thus alternatively, detection of reactive IgG
y  using recombinant T. canis antigens (Yamasaki et al.,
000;  Wickramasinghe et al., 2008; Mohamad et al., 2009)
s  well as IgE antibodies in ELISA may  conveniently obtain
onvincing results (Norhaida et al., 2008). Moreover, detec-
ion  of IgG subclasses seems also valid in immunodiagnosis
f Toxocara spp. infection and among the four human IgG
ubclasses, speciﬁc IgG2 antibodies to glycan of TES anti-
ens  yield the highest sensitivity but suffer from reducedlogy 193 (2013) 342– 352
speciﬁcity in ELISA (Watthanakulpanich et al., 2008), while
the  ﬁnding of reactive IgG4 antibodies probably against
protein contributes to increased speciﬁcity (Noordin et al.,
2005).  However, it is also possible to detect Toxocara spp.
DNA  from tissues in suspected clinical toxocarosis by PCR
(Caldera  et al., 2012).
4.  Global seroprevalence
Globally epidemiological studies indicate that the sero-
prevalence of T. canis infection in people living in developed
countries was in general relatively low, e.g. 13.9% in USA,
2.4%  in Denmark, 1.6% in Japan, 0.7% in New Zealand and
7.5%  in Australia; in contrast, higher seroprevalences are
found  in developing countries e.g. 93% in La Reunion, 81% in
Nepal,  63.2% in Indonesia, 58% in Malaysia, 44.6% in Swazi-
land,  36% in Brazil and 30% in Nigeria (Smith and Noordin,
2006; Liao et al., 2010). Recent seroprevalence studies of
T.  canis infection among schoolchildren in African Swazi-
land  and Sao Tomes and Principe conducted in 2010 appear
very  high, reaching 86.4% (n = 360) and 98.8% (n = 255),
respectively as assessed by TES-WB (Fan et al., unpublished
data). However, a valid comparison of seroprevalence data
between  countries is hampered by the variation in detec-
tion  methods (ELISA or western blots) and cut-off titres
and  by the general difﬁculty in exploring the relationships
between titres, infection and clinical disease (Alderete
et al., 2003; Smith et al., 2009). Altogether, seroepidemio-
logical studies of Toxocara spp. infection indicate that T.
canis  larvae impose a severe impact on worldwide human
health  and cannot be ignored.
5.  Immunopathogenesis of toxocarosis
In the paratenic hosts like mice and humans, T. canis L3
larvae  neither moult, grow nor replicate (Smith et al., 2009).
Although studies concerning humoral immune response
e.g.  IgG subclass response and cellular immune response
e.g.  cytokine expression from clinical toxocarosis patients
are  limited, Obwaller et al. (1998) reported that the pre-
dominant IgG subclass in toxocarosis patients with VLM,
OLM  or asymptomatic individuals was  IgG1 followed by
IgG2,  IgG4 and IgG3 by using a TES ELISA. Subclasses IgG1,
2  and 4 showed signiﬁcant differences between the sera
of  VLM patients and asymptomatics, but not between OLM
patients  and asymptomatics, while Malla et al. (2002) indi-
cated  that signiﬁcantly higher IL-5 expression was found in
human  toxocarosis as compared to normal healthy subjects
in  India. Since IgG4 reﬂects prolonged antigenic stimula-
tion  (Obwaller et al., 1998), it seems an ideal diagnostic
marker to monitor whether any viable larvae reside in the
body  with toxocarosis before or after treatment. The patho-
genesis  of toxocarosis in mice resembles that in humans,
mice are easy to handle and experimentally infect with
easily  controlled inoculation of eggs to experimental ani-
mals,  hence mice are a good model for human infection
allowing the study of the immune response and associ-
ated immunopathological injuries in the murine hosts. This
approach  has been exploited by many laboratories (Smith
and  Noordin, 2006).
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The immune response may  include both humoral and
tissue  factors. Although mouse isotypes (IgG1, IgG2a, IgG2b
and  IgG3) are different from human (IgG1, IgG2, IgG3 and
IgG4);  in a study in mice using a TES ELISA, the time and
inoculum-dependent increases in serum IgG1 were found
to  be greater than for IgG2a (Pinelli et al., 2007). Fan et al.
(2003)  found that although IgG1 antibody is the primary
responder it did not seem to have a larvicidal effect with
no  correlation being observed between the level of IgG1
and  the decrease in mean total larval recovery in mice; on
the  contrary, the murine IgG1 antibodies may  cause patho-
genesis  related to immediate-type hypersensitivity thus
leading  to tissue damage instead of killing the T. canis lar-
vae  in the tissues. Murine model studies also indicated that
granulomatous reactions may  occur after frequent expo-
sure.  Pathological studies indicated that granulomatous
inﬂammation characterized by aggregates of eosinophils,
neutrophils, and some monocytes, and the larvae are par-
tially  surrounded by an abundant collagen capsule. The
larvae  are often gradually encapsulated by mature gran-
ulomas with the central portion formed by mononuclear
cells or leucocytes (Fan et al., 2003; Lin et al., 2008; Wu
et  al., 2008). Substantial studies have indicated that TES is
able  to trigger the inﬂammatory response, so that is the rea-
son  why the larvae are not found in many granulomas and,
even  if found, they are intact and presumably viable (Kayes,
1997;  Fan et al., 2003; Lin et al., 2008; Wu  et al., 2008).
Moreover, the pathological consequences mainly depend
on  the death of the larvae of T. canis; although viable lar-
vae  may  cause ocular pathology found in OT. Larval death
triggers the beginning of early and delayed hypersensitivity
responses (Despommier, 2003). The formation of granulo-
mas  seems complicated and the event usually constitutes
a  mixed Th1- and Th2-mediated immunological response
resulting in a manifestation of delayed hypersensitivity
(Th1) coincided with IgE and eosinophilia which are typical
of  Th2-mediated responses (Kayes, 1997).
The reason for the development of the symptomatic
syndrome of VLM is not completely clear but the incrim-
inating factors are believed to be related to the types
of  immune response involved. The major host responses
to  the larval antigens include marked eosinophilia and
hypergammaglobulinaemia e.g. IgE and IgG antibodies and
eosinophils  are manifestations of Th2 type cells and of
the  cytokines e.g., IL-4, IL-5, and IL-13 secreted by these
cells.  Also, there is reason to believe that the antigens
released from the T. canis larvae prompt the induction
of this population of cells. There is much evidence that
the  persistent release of parasite antigens may  continu-
ously stimulate host immune system with concomitant
production of eosinophils and IgE antibodies thus causing
systemic complications. The primary role of eosinophils is
to  eliminate antibody-bound parasites through the release
of  cytotoxic granule proteins (Giembycz and Lindsay,
1999). IL-5 is a major regulator of eosinophil accumu-
lation in inﬂamed tissues and can modulate eosinophil
behaviour at every stage from maturation to survival. IL-4
induces  B-cell class switching to IgE and IgG4, and up-
regulates major histocompatibility complex (MHC) class
II  production; in contrast, IL-4 decreases the production
of Th1 cells, macrophages, IFN-, and IL-12 expression oflogy 193 (2013) 342– 352 345
dendritic  cells (Hosoyama et al., 2011). Tissue macrophages
play an important role in chronic inﬂammation and wound
repair.  The presence of IL-4 in extravascular tissues pro-
motes  macrophages alternatively activated in vitro (M2
cells)  and inhibits classical activation of myeloid precur-
sor  cell line into M1  cells which differentiate in response
to  cytokines and expresses many characteristics of tissue
macrophages (Jelachich et al., 1999). An increase in repair
macrophages (M2) is coupled with secretion of IL-10 and
transforming growth factor beta (TGF-) that result in a
diminished pathological inﬂammation thus leading to fur-
ther  development of wound repair and/or ﬁbrosis (Luo
et  al., 2012). However, both eosinophilia and hyperglob-
ulinaemia, are apparently ineffective at ridding the body of
infective  larvae.
Substantial evidence has indicated that TGF-1 played
an  important role in maintenance of immunological bal-
ance  in various parasitic infections e.g., mice expressing
a  T-cell-speciﬁc dominant-negative TGF- receptor II
show  dampened Th2 immunity and diminished resis-
tance to Heligmosomoides polygyrus infection (Reynolds
and Maizels, 2012), as well as the production of anti-
inﬂammatory cytokines derived from Th2 cells stimulation
by  TGF-1 are necessary to down-regulate proinﬂam-
matory cytokines in murine schistosomiasis (Brunet et al.,
1998),  suggesting that TGF-1 might be important in main-
taining  the balance between protection and pathology in
parasitic  infections (Omer et al., 2000).
There is much interest in the role of TGF-1 in
immunopathogenesis of toxocarosis. Recent studies have
indicated  that during T. canis larval penetration through the
small  intestine or invasion of the liver or brain, enhanced
TGF-1 expressions were observed mainly in inﬁltrated
leucocytes surrounding the granulomatous inﬂammatory
sites in the small intestine (Fan et al., 2004b), musculature
(Fan, unpublished data), and liver (Wu et al., 2008) or astro-
cytes  in the injured brain (Liao et al., 2008). Nevertheless,
until now, the underlying molecular and immunological
mechanisms associated with TGF-1/Th2 responses that
may  lead to protection against or resistance to Toxocara
spp. larval invasion as well as the associated manifestation
caused by immunopathological changes are largely unclear
and  require further elucidation.
Substantial evidence has indicated that exposure to a
pathogen is regulated by ecological and behavioural factors
through  genetic control (Quinnell, 2003; Dold and Holland,
2011).  Since the ability of hosts to regulate parasites and
thus  control resistance or susceptibility at an individual
and population level, through either innate or acquired
immune responses, is a very important determinant of host
variation  in susceptibility to helminth infection which are
ultimately determined by host genetics (Quinnell, 2003);
therefore, recent emphasis has been placed on investigat-
ing various immunological parameters and genetic factors
as  possible contributors to the predisposition to helminth
infections (Dold and Holland, 2011); as whether this issue
is  also the same to Toxocara spp. infection warrants fur-
ther  exploration. Immunologically, helminth infections are
associated  with polarized CD4+ Th2 responses and with
high  IgE levels. Moreover, substantial studies have indi-
cated  that the immune defence against various infectious
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iseases e.g. HIV/AIDS, viral hepatitis, leprosy, tuberculosis,
alaria, leishmaniasis, and schistosomiasis may  be highly
nﬂuenced by the complex interaction of environmental
nd host genetic factors e.g. MHC  genes (Quinnell, 2003;
uitton et al., 2006). Gene families of the human MHC  class I
nd  II, also known as human leucocyte antigen (HLA), show
xtensive  nucleotide and allelic polymorphism (Blackwell
t  al., 2009) and it is estimated that approximately 40%
f  the 224 identiﬁed genes are associated with func-
ions of the immune system (MHC sequencing consortium,
999). The classical HLA loci are the class I (HLA-A, -B,
C,  -E, -F, and -G) and class II (HLA-DR, -DQ, -DM, and -
P)  molecules identiﬁed for their role in presentation of
ntigen  to CD8+and CD4+ T-cells, respectively. They are
ncoded by a 4-Mb region of human chromosome 6p21
hat  is recognized as the most variable region in the human
enome (Blackwell et al., 2009) because of the important
ole played by class I and class II molecules in recogni-
ion of self versus non-self. Since the MHC  gene products
re involved in the regulation of T-cell function, there
as  been much focus on investigating the involvement of
HC-linked genes coupled with genes for cytokine and
hemokine receptors in controlling resistance to helminth
nfection (Blackwell et al., 2009). HLA class II molecules
re therefore considered functionally important and the
enes  encoding them are potential susceptibility loci; how-
ver,  although some studies indicated that no linkages at
he  HLA region were observed in a genome-wide linkage
can  (GWLS) using either Ascaris or Schistosoma mansoni
urden as a clinical phenotype (Quinnell, 2003), May  et al.
1998)  showed a strong association between infection with
.  haematobium and DP alleles; Holland et al. (1992) found
 weak association between the HLA-A30/31 antigen and
he  Nigerian children who had consistent Ascaris infection,
hile recently, De Angelis et al. (2012) found that the key
ole  of several HLA-DQA1 alleles in susceptibility and pro-
ection  against onchocerciasis in Ecuador. Currently, there
re  substantial studies focusing on associations between
LA  and pathological severity caused by various parasitic
nfections, particularly immune response genes potentially
nvolved in the control of Th2 responses. For example,
any HLA association studies have been performed for
evere  schistosomal pathology. Associations between hep-
tosplenomegaly in patients infection with S. mansoni and
lass  I antigens, particularly B5, have been reported in
ost  Egyptian studies but not a Brazilian study; studies of
lass  II antigens have been more variable, with DR3 asso-
iated  with disease (Assaad-Khalil et al., 1993) and DR2
ssociated with absence of disease in Egypt (Hafez et al.,
991),  while DQB1*0201 was associated with disease in
razil  (Secor et al., 1996). Strong associations have also
een  reported between hepatic disease and HLA alleles
n  Schistosoma japonicum, though both the class I and II
lleles  involved vary between studies (Quinnell, 2003).
hese associations with pathology may  reﬂect HLA control
f  immune responsiveness to parasites, and some alleles
ssociated with increased pathology are also associated
ith increased lymphocyte responsiveness to schistosome
ntigens (Ohta et al., 1982). As predisposition to helminth
nfections and disease severity are supposedly related to
arious  immunological parameters through manipulationlogy 193 (2013) 342– 352
of  genetic factors, whether this issue is also the same to
Toxocara spp. infection warrants further exploration.
However, some studies investigating behavioural-
mediated acquisition as well as disease severity of Toxocara
spp.  infection indicated that they may  include e.g. num-
ber  of larvae ingested, frequency of infective eggs intake,
host  immune response to invading larvae as well as lar-
val  secreted and/or excreted products, and inﬂammatory
reactions elicited by the larvae in the tissues (Glickman
and Schantz, 1981; Carvalho and Rocha, 2011). In a murine
model study, Epe et al. (1994) examined the behaviour and
pathogenicity of T. canis larvae in different mouse strains
with  different MHC  haplotype including inbred strains
BALB/c (H-2d), C3H/He (H-2k), C57BL/6j (H-2b), and DAB/2j
(H-2d) and the outbred strain NMRI. The highest larval
counts in the brain of all strains were found in BALB/c mice.
The  percentage of eosinophils in the blood of BALB/c mice
increased after the 8th week p.i., whereas it decreased in
the  other strains, with histological and pathophysiologi-
cal changes of a lesser extent in BALB/c strain than in the
others.  In mice of the strains C3H/He and C57BL/6j, deaths
occurred from the 4th week p.i. onward, and the number of
larvae  found in their brains was  lower than those observed
in  BALB/c. Koizumi and Hayakawa (1984) showed that
higher number of larvae recovered from the liver of BALB/c
than  that in C57BL/6j and C3H/He mice infected by T. canis.
These  ﬁndings did not seem to be explained sufﬁciently
by MHC  related immunity, although comparison is difﬁcult
unless  MHC-congenic strains are compared. There is no evi-
dence  that mechanical damage caused by migrating larvae
in  the brain tissue is mainly responsible for symptoms of
central  nervous toxocarosis. Thus, the assumption that the
MHC  is involved in the allergic-inﬂammatory response in
the  brain could not be proven because infected mice of the
BALB/c  and DAB/2j strains reacted completely differently,
although both are equipped with the same MHC  haplo-
type. As whether MHC  polymorphism is possibly involved
in  determination of susceptible or resistant to T. canis
infection and associated manifestation severity in human
toxocarosis remains largely unknown.
6. Environmental factors contributing to
manifestation severity of human toxocarosis
The effects of host genetics are usually considered to
be  on resistance to infection, through effects on innate or
acquired  immunity. Thus, there may  be genetic control of
parasite  survival, growth or fecundity. Accordingly, suscep-
tibility/resistance to parasitic infections should be highly
related  to host polygenic factors instead of monogenic
factors. However, there could also be genetic effects on
exposure to infection through, for example, environmental
and/or behavioural genes affecting hygiene behaviour or
geophagy.  This hypothesis is supported by the observation
that at least a proportion of the 3–14% variance of worm
burden is explained by environmental effects (Quinnell,
2003). However, variation in exposure between hosts is
likely  to be large, reﬂecting the aggregated distributions of
infective  stages in the environment e.g. hookworm larvae
or  Ascaris eggs in soil and contacts with the environment,
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o 2012, 
ca has 2Fig. 1. Analysis of the clinical toxocarosis cases from PubMed from 1990 t
by  Asia with 104 cases and then North America has 62 cases, Latin Ameri
Tunisia.  Black bar indicates total number of cases in individual continent.
such as geophagy and schistosome infective water contact
(Quinnell, 2003).
The  physical environment plays a crucial role in main-
taining and distributing the infective T. canis eggs provided
that  there are suitable conditions. Infective T. canis eggs
can  last for months to years outside the host under opti-
mal  conditions because of a resistant outer acellular shell
which,  in the laboratory, has been shown to protect against
various  harsh chemicals e.g. formalin, various inorganic
acids, extreme temperature changes and various degrees
of  moisture. Practical assessment of frequency of exposure
to  environmental embryonated eggs or encapsulated lar-
vae  for individual toxocarosis patients is difﬁcult, including
correlating exposure to soils contaminated by T. canis infec-
tive  eggs geophagic behaviour, or potential risk factors for
exposure  such as socioeconomic status, education or access
to  sanitation, but may  be useful in future genetic studies.
Analysis of the clinical toxocarosis cases from PubMedline
from 1990 to 2012, show a total of 290 papers with 368
reported cases. Interestingly, Europe has the most cases,
169,  followed by Asia with 104 cases and then North Amer-
ica  with 62. In Latin America 27 cases were reported; in
Australia, 5 cases. Only one case is reported from Tunisia
(Fig. 1). By country distribution, France, Japan, USA, and
Brazil  reported the highest number of cases (49 (29%), 31
(30%),  61 (98%), and 20 (74%)) respectively. It is noteworthy
that most of the reported cases are of OLM with symptoms
(Fig. 2).
In  clinical toxocarosis cases, the pathogenic mecha-
nisms of VLM and OLM are different. Smaller amounts of
Toxocara  spp. larvae infections seem to favour the devel-
opment of OLM than VLM, reﬂecting why antibody titres of
Toxocara  spp. are generally lower in cases of OLM than in
cases  of VLM. Biopsied materials taken from clinical cases
and  experimentally infected animals indicated that vari-
ous  tissue invasion by larvae may  elicit a Th2-dominant
granulomatous inﬂammation which may  lead to frequent
encapsulation of the T. canis larva in the host tissue, alter-
natively it can be considered a reaction that promotes
long stay and prolonged infectivity of the larvae in hoststotally 368 cases are reported. Europe has the most cases of 169, followed
7 cases, Australia has 5 cases, and only one case is reported from African
(Glickman and Schantz, 1981; Fan et al., 2003). According
to  the report from Pena et al. (2011) there is a high genetic
similarity between Brazilians and Europeans, which may
explain  why  disease development is similar in the Brazilian
and  French populations acquiring Toxocara spp. infection.
Despite different genetic backgrounds, living conditions
and environmental exposure factors e.g. soil in parks con-
taminated with embryonated eggs, OLM predominates in
human  toxocarosis cases in Japan, America and France. It
has  been reported that if people accidentally ingest small
numbers of T. canis ova through constant exposure to con-
taminated environments, this may  lead to OLM. Toxocara
spp.  eggs contaminating urban public parks is very com-
mon  in most countries, regardless of whether the country
is  developed or developing (Jarosz et al., 2010; Manini
et  al., 2012). Since human seropositivity can be observed
in  areas where the soil is contaminated by eggs of Toxocara
spp., the risk increases according to the degree of environ-
mental contamination (Won  et al., 2008); however, risk
factors  may  differ among regions (Andrade et al., 2001).
The  growing number of pet animals, mainly in large urban
centres, has led to closer contact of these animals with
humans, increasing the degree of exposure (Gennari et al.,
1999).  Nevertheless, the exploration of different MHC  poly-
morphism  between those patients from these countries
assessed by using single-nucleotide polymorphisms (SNPs)
should  be anticipated in the future to examine the dis-
crepancy in disease development and severity between
different ethnic groups with Toxocara spp. infection.
7. TGF-1 may  play a pivotal role in manifestation
severity in toxocarosis by regulation of CD4+ T-cell
subsets  through modulation of Foxp3 expression:
promising prospects?
The  larvae of Toxocara spp. in the tissues induce gran-
ulomatous inﬂammation whose eosinophilic component
is  prominent. Most of the pathology in this infection
results from tissue damage by the inﬂammatory responses
to  the presence of larvae and the activity of TcnES
348 C.-K. Fan et al. / Veterinary Parasitology 193 (2013) 342– 352
F st toxoc
t le orga
t  web ve
a
e
r
f
d
e
(
a
t
b
C
p
T
s
p
C
a
p
p
T
a
F
s
t
d
c
i
2
a
a
h
i
(ig. 2. By country distribution, France, Japan, USA, and Brazil has the mo
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he  references to colour in this ﬁgure legend, the reader is referred to the
ntigens produced by the larvae (Kayes, 1997; Magnaval
t  al., 2001). T. canis infection elicits both Th1 and Th2
esponses with predominance of the second. Granuloma
ormation is considered a manifestation of Th1-mediated
elayed-hypersensitivity, whereas high levels of IgE and
osinophilia are predominantly mediated by Th2 responses
Kayes, 1997; Kuroda et al., 2001).
T regulatory (Treg) cells have been recently described
s an essential component of the immune system for
he  maintenance of T-cell homeostasis. These cells have
een  characterized by constitutive expression of CD4+ and
D25+ (IL-2 receptor a chain) on the cell surface and by the
resence of Forkhead box p3 (Foxp3) (Sakaguchi, 2005).
reg  cells are anergic and do not produce IL-2. Instead, on
timulation, they suppress the proliferation and cytokine
roduction of conventional CD4+ T-cells, as well as that of
D8+ T-cells and established Th1 and Th2 cells (Piccirillo
nd Shevach, 2004; Chatila, 2005). Moreover, these cells
lay  an important role in chronic infections, particularly
arasitic diseases (Belkaid et al., 2002). The CD4+CD25+
reg subset, which spontaneously arises in the thymus, can
lso  be peripherally induced by antigen (Zhang et al., 2001).
oxp3-deﬁcient (−/−) mice and patients were found to be
uffering from immune dysregulation, polyendocrinopa-
hy, enteropathy, X-linked syndrome, where mutations or
eletions  in the foxp3 gene halts the development of Treg
ells  and consequentially, leads to a fatal autoimmune and
nﬂammatory disease (Bennett et al., 2001; Fontenot et al.,
003).
Foxp3-expressing cells have recently been recognized
s a cornerstone for the homeostasis of the immune system,
nd  as key cells in many infectious diseases. Moreover, they
ave  been found to contribute to the regulation of parasite-
nduced immunopathology in many parasitic infections
Maizels and Smith, 2011). Chronic infection witharosis cases in European, Asian, North, and Latin American cases, respec-
ns involved (orange coloured bar indicating other). (For interpretation of
rsion of the article.)
S.  mansoni, which creates extensive damage of liver,
illustrates such control. Only tight control of the egg-
induced immune response allows survival of the infected
host  (Hoffmann et al., 2000). However, it was  shown
that immunosuppressive CD4+CD25+ Treg isolated from
hepatic granulomas and from lymphoid tissues are a main
producer of IL-10 in schistosome-infected mice (McKee and
Pearce,  2004).
On  the other hand, when natural Treg successfully pre-
serves host homeostasis by controlling excessive immune
responses, one consequence of such control is enhanced
pathogen survival and, in some cases, long-term pathogen
persistence. Parasite persistence due to immune suppres-
sion  by natural Treg also provides a major beneﬁt to the
host  by maintaining life-long immunity to reinfection.
However, in some cases, regulatory control is excessive;
this allows the parasite to expand in an uncontrolled man-
ner  and thus fails to secure host survival e.g. depletion of
natural  Treg protected mice from death caused by the lethal
strain  of Plasmodium yoelii by restoring a vigorous effector
immune response, which eradicated the parasites (Hisaeda
et  al., 2004). Because Treg offer an opportunity for para-
sites  to generate favourable conditions for persistence, it
is  conceivable that their induction and survival can also be
manipulated by parasites. The anti-inﬂammatory cytokine
TGF-1,  which is produced at high levels during chronic
parasitic infections, is also an important factor for the local
survival  and function of Treg (Green et al., 2003). It has
been  conﬁrmed that TGF-1 is able to promote nTreg cell
expansion as well as generation of Foxp3+ inducible Treg
cells  from CD4+CD25− T-cells as manipulation through IL-
10  expression (Pyzik and Piccirillo, 2007).
Interestingly, Othman et al. (2011) recently found a
progressive increase in Foxp3-expressing cell counts in
the  liver starting 5 weeks p.i., these cells were detected
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Fig. 3. Inﬁltrated leucocytes with signiﬁcant transforming growth factor-
Fig. 4. Inﬁltrated leucocytes with signiﬁcant transforming growth factor-
1  expression (arrow) in granulomatous inﬂammation in liver (100×)
genotype do not develop into severe pathological syn-
dromes warrants further elucidation in the future.1  expression (arrow) in granulomatous inﬂammation in small intestine
(400×) from mice orally inoculated with 250 Toxocara canis embryonated
eggs assessed by immunohistochemistry.
within and around Toxocara spp.-induced granulomas as
well  as in isolated inﬂammatory foci in the portal tracts
or  within the hepatic parenchyma. Likewise, expression
of  Foxp3 mRNA in the spleen signiﬁcantly increased
at 5 and 16 weeks p.i. Furthermore, immunization of
mice  with TES antigen prior to experimental infection
caused earlier mobilization and recruitment of Foxp3+
cells to the liver and enhanced splenic expression of
Foxp3 transcripts. These results suggest a potential role of
Foxp3-expressing regulatory cells in the evolution of the
immunopathological events during infection by T. canis.
This  may  be considered alongside the ﬁndings of Wu
et  al. (2008) who demonstrated enhanced expression of
TGF-1  in inﬂammatory cells as early as 4 weeks p.i. in
experimental granulomatous hepatitis caused by T. canis;
thereby  providing indirect evidence for the presence of
Treg,  although TGF-1 is also produced by many other cell
types.  Further studies may  also indirectly support TGF-
1  playing an important role in the regulation of Treg
as  evidenced by the fact that during T. canis larval pen-
etration through the small intestine or when invading the
liver  or brain, enhanced TGF-1 expressions were observed
mainly in inﬁltrated leucocytes surrounding the granulo-
matous inﬂammatory sites in the small intestine (Fig. 3),
liver  (Fig. 4), and musculature (Fig. 5) or by astrocytes in
the  injured brain. Interestingly, partial inhibition of TGF-
1  expression may  lessen the pulmonary injury caused
by  experimental toxocaral pneumonia by reducing some
chemokine expression e.g. eotaxin (Fan et al., unpublished
data) as well as injury associated biomarkers expressions
e.g. GFAP in the experimental neurotoxocorisis (Fan et al.,
unpublished data).
Recent  evidence indicates that there is a substantial
genetic component to the control of TGF-1 concentration
in blood circulation (Grainger et al., 1999). Several stud-
ies  have shown associations between certain SNPs, such
as  +869T-C and Leu10Pro, and increased serum concentra-
tion  of TGF-1 in human beings (Grainger et al., 1999).
It  has been suggested that the Leu10Pro polymorphismfrom mice orally inoculated with 250 Toxocara canis embryonated eggs
assessed by immunohistochemistry.
may  account for some of the reported associations of TGF-
1  with these diseases e.g. cancer (Colletta et al., 1991),
systemic sclerosis, pulmonary ﬁbrosis, osteoporosis, and
atherogenesis (Grainger et al., 1995). This is based on sev-
eral  studies (Grainger et al., 1999; Dunning et al., 2003) that
have  shown that the Pro10Pro genotype produces more
serum  TGF-1 while the Leu10Leu genotype produces less.
Recently,  an association was  found between the TGF-1
Leu10Pro variant and lack of Mf  in the blood. The latent (cir-
culating  ﬁlarial antigen (CFA)+; microﬁlaria (Mf)−) group
had  a higher frequency of the Leu10Leu genotype, which
produces less TGF-1, than Mf+  patients (Debrah et al.,
2011). Whether this is also true in toxocarosis patients with
Pro10Pro  genotype who  have apparent symptoms due to
severe  pathological injury, while patients with Leu10LeuFig. 5. Inﬁltrated leucocytes with signiﬁcant transforming growth factor-
1  expression (arrow) in granulomatous inﬂammation in musculature
(100×) from mice orally inoculated with 250 Toxocara canis embryonated
eggs assessed by immunohistochemistry.
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. Conclusion
Epidemiological study has indicated that if children
nder 5 years old acquire T. canis infection, they will usually
evelop  covert toxocarosis or VLM if they develop a symp-
omatic syndrome, while infected adolescents or adults
ith  overt symptoms tend to develop OLM, although both
hildren  and adults can develop covert toxocarosis or one
f  the overt syndromes. Immunological studies indicated
hat  a mixed type of Th1 (minor) and Th2 (predominant)
ediated immunopathological changes emerged in the
ocal  organs invaded by T. canis larvae although it depends
ow  many larvae are ingested, the frequency of intake
f  infective eggs, the host immune response to invading
arvae as well as larval secretory and/or excretory prod-
cts  and inﬂammatory reactions elicited by the larvae in
he  tissues. Genetically, Toxocara spp. infections are asso-
iated  with polarized CD4+ Th2 responses with high IgE
evels  and eosinophilia, HLA class II molecules, potential
usceptibility loci, are considered involved in the disease
evelopment and severity of experimental toxocarosis.
he regulation of such Th2-dominant immunity is highly
ontrolled by Foxp3+ CD4+CD25+ Treg cells as stimulated
hrough TGF-1 thus providing a beneﬁcial environment
o T. canis larvae but severe injuries to local organs. How-
ver,  whether TGF-1 variant Leu10Pro is involved in the
isease  severity of human toxocarosis warrants further elu-
idation.  Therefore, exploration of the expressions of Th1-,
h2-mediated cytokines, TGF-1 polymorphism, Foxp3+
D4+CD25+ Treg cells, and MHC  polymorphisms from clini-
al  toxocarosis patients may  allow insight into complicated
nteractions between environmental and genetic factors
ontribution to disease type and the severity of human
oxocarosis in the future.
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